Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the COVID-19 (COVID-19) Current Therapy Market for the Period 2024 to 2033?

In recent times, the market size for current therapies dealing with coronavirus (covid-19) has plummeted drastically. An expected fall from $11.73 billion in 2023 to $5.87 billion in 2024, approximately a -50.0% compound annual growth rate (CAGR), is forecasted. The cause for this decrease during the historic period is attributed to a scarcity of treatment alternatives, inconsistency in treatment effectiveness, issues in the supply chain, accelerated advancement in scientific understanding and the development of new variants.

The market size for current treatment options for the coronavirus (covid-19) is projected to experience a steep downturn in the coming years. A drop to $2.34 billion by 2025 is expected, reflecting a compound annual growth rate (CAGR) of -60.1%. Factors such as the impact of global vaccine distribution, long-term effects and chronic cases, regulatory hurdles and market access issues, along with global economic factors, are contributing to this decline throughout the forecast period. Meanwhile, major trends within this period involve investments in the development of monoclonal antibody therapies, convalescent plasma therapies, cell-based therapies, and antiviral therapies. Collaborations with government bodies and creating strategic partnerships with other drug companies are also prevalent.

Claim Your Free Sample of the Global COVID-19 (COVID-19) Current Therapy Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp

What Factors Are Responsible for the Growth of the covid-19 (covid-19) current therapy Market?

The proliferation of the COVID-19 pandemic has significantly driven the growth of the prevailing coronavirus therapy market. The global pandemic was declared by the World Health Organization (WHO). To elaborate, according to the WHO, an affiliate of the United Nations based in Switzerland, the total cases of COVID-19 worldwide reached 581.8 million by August 2022. As there is no authorized medication for COVID-19, the requirement for repurposed drugs used for COVID-19 therapy has noticed a substantial increase. All world countries are grappling with drug shortages while drug manufacturers are doing their best to increase production to meet worldwide demand. The special emergency program, Coronavirus Treatment Acceleration Program (CTAP), has been launched by the FDA to ensure rapid development and availability of potential therapies for COVID-19.

Which Segments Are Important for Insight into the COVID-19 (COVID-19) Current Therapy Market?

1) By Drug Type: Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs, Others

2) By Route Of Administration: Oral, Intravenous

3) By End-User: Hospitals, Clinics, Home Care, Others

What Are the Significant Trends Reshaping the COVID-19 (COVID-19) Current Therapy Sector?

The Convalescent Plasma Therapy, being trialed as a treatment method for COVID-19, uses the blood plasma from patients who have overcome the virus, known as Convalescent Plasma (CP). This process, a form of passive antibody therapy, involves extracting blood plasma from recovered patients of the relevant disease and providing it to patients with the disease in a severe form, the aim being to reduce virulence and alleviate clinical symptoms. The blood plasma from patients who have recovered from COVID-19 contains antibodies that fight the virus. As per FDA guidelines, the Convalescent Plasma Therapy is advocated as an investigational product during a public health crisis. Until now, around 2,004 sites have been following a single expanded access protocol registered by the US FDA. Approximately 7,774 patients have been admitted to the trial and 3,809 have received the Convalescent Plasma transfusion. If supported by sufficient data, the experimental Convalescent Plasma therapy could gain significant attention.

Order Now for Fast Delivery of Your COVID-19 (COVID-19) Current Therapy Market Report!

https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report

Which Regions Are Essential for the Growth of the COVID-19 (COVID-19) Current Therapy Market?

North America is the largest region in the coronavirus (COVID-19) current therapy market in 2023. Middle East is expected to be the fastest growing region in the global coronavirus (COVID-19) current therapy market share during the forecast period. The regions covered in the coronavirus (covid-19) current therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The COVID-19 (COVID-19) Current Therapy Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the covid-19 (covid-19) current therapy market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The COVID-19 (COVID-19) Current Therapy Market Include

1. COVID-19 (COVID-19) Current Therapy Market Executive Summary

2. COVID-19 (COVID-19) Current Therapy Market Segments

3. COVID-19 (COVID-19) Current Therapy Market Size And Template Market Growth Rate

4. Key COVID-19 (COVID-19) Current Therapy Market Trends

5. Major COVID-19 (COVID-19) Current Therapy Market Drivers

……

25. Key Mergers And Acquisitions In The COVID-19 (COVID-19) Current Therapy Market

26. Top COVID-19 (COVID-19) Current Therapy Companies

27. COVID-19 (COVID-19) Current Therapy Market Opportunities And Strategies

28. COVID-19 (COVID-19) Current Therapy Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

COVID-19 (COVID-19) Current Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report

Anti-Viral Drug Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

COVID-19 Drug Associated APIs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: